Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+72.1%
5Y CAGR+42.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+72.1%/yr
vs +12.5%/yr prior
5Y CAGR
+42.0%/yr
Recent acceleration
Acceleration
+59.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $56.38M | +189.2% |
| 2024 | $19.49M | +136.8% |
| 2023 | $8.23M | -25.5% |
| 2022 | $11.05M | -66.2% |
| 2021 | $32.73M | +235.6% |
| 2020 | $9.75M | +14.0% |
| 2019 | $8.56M | +24.1% |
| 2018 | $6.89M | -25.1% |
| 2017 | $9.21M | -82.5% |
| 2016 | $52.65M | - |